These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 27775145)
1. Loading of an anti-cancer drug into mesoporous silica nano-channels and its subsequent release to DNA. Koninti RK; Palvai S; Satpathi S; Basu S; Hazra P Nanoscale; 2016 Nov; 8(43):18436-18445. PubMed ID: 27775145 [TBL] [Abstract][Full Text] [Related]
2. Imidazolium-based ionic liquid functionalized mesoporous silica nanoparticles as a promising nano-carrier: response surface strategy to investigate and optimize loading and release process for Lapatinib delivery. Peyvand P; Vaezi Z; Sedghi M; Dalir N; Ma'mani L; Naderi-Manesh H Pharm Dev Technol; 2020 Nov; 25(9):1150-1161. PubMed ID: 32746669 [TBL] [Abstract][Full Text] [Related]
3. A Smart pH-responsive Nano-Carrier as a Drug Delivery System: A hybrid system comprised of mesoporous nanosilica MCM-41 (as a nano-container) & a pH-sensitive polymer (as smart reversible gatekeepers): Preparation, characterization and in vitro release studies of an anti-cancer drug. Abbaszad Rafi A; Mahkam M; Davaran S; Hamishehkar H Eur J Pharm Sci; 2016 Oct; 93():64-73. PubMed ID: 27497878 [TBL] [Abstract][Full Text] [Related]
4. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol. Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300 [TBL] [Abstract][Full Text] [Related]
5. How Molecular Mobility, Physical State, and Drug Distribution Influence the Naproxen Release Profile from Different Mesoporous Silica Matrices. d'Orey P; Cordeiro T; Lourenço MAO; Matos I; Danède F; Sotomayor JC; Fonseca IM; Ferreira P; Correia NT; Dionísio M Mol Pharm; 2021 Mar; 18(3):898-914. PubMed ID: 33461296 [TBL] [Abstract][Full Text] [Related]
6. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique. Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738 [TBL] [Abstract][Full Text] [Related]
7. Inclusion and release of fenbufen in mesoporous silica. Carriazo D; del Arco M; Fernández A; Martín C; Rives V J Pharm Sci; 2010 Aug; 99(8):3372-80. PubMed ID: 20232455 [TBL] [Abstract][Full Text] [Related]
8. Adsorption and release of ampicillin antibiotic from ordered mesoporous silica. Nairi V; Medda L; Monduzzi M; Salis A J Colloid Interface Sci; 2017 Jul; 497():217-225. PubMed ID: 28285049 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of MCM-48/hydroxyapatite composites for drug delivery: Ibuprofen incorporation, location and release studies. Pajchel L; Kolodziejski W Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():734-742. PubMed ID: 30033308 [TBL] [Abstract][Full Text] [Related]
10. Dendritic silica nanomaterials (KCC-1) with fibrous pore structure possess high DNA adsorption capacity and effectively deliver genes in vitro. Huang X; Tao Z; Praskavich JC; Goswami A; Al-Sharab JF; Minko T; Polshettiwar V; Asefa T Langmuir; 2014 Sep; 30(36):10886-98. PubMed ID: 25188675 [TBL] [Abstract][Full Text] [Related]
11. Multifunctional materials such as MCM-41÷Fe3O4÷folic acid as drug delivery system. Popescu S; Ardelean IL; Gudovan D; Rădulescu M; Ficai D; Ficai A; Vasile BŞ; Andronescu E Rom J Morphol Embryol; 2016; 57(2):483-9. PubMed ID: 27516022 [TBL] [Abstract][Full Text] [Related]
12. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium. Xie Z; Gong H; Liu M; Zhu H; Sun H J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096 [TBL] [Abstract][Full Text] [Related]
13. [Study on the interaction of levofloxacin and MCM-41 by fluorescence spectrum]. Cao Y; Yuan QH; Xia ZN; Xu YQ; Bai YH Guang Pu Xue Yu Guang Pu Fen Xi; 2009 Sep; 29(9):2527-30. PubMed ID: 19950667 [TBL] [Abstract][Full Text] [Related]
14. Excited state proton transfer dynamics of an eminent anticancer drug, ellipticine, in octyl glucoside micelle. Gavvala K; Koninti RK; Sengupta A; Hazra P Phys Chem Chem Phys; 2014 Jul; 16(28):14953-60. PubMed ID: 24931633 [TBL] [Abstract][Full Text] [Related]
15. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect. Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253 [TBL] [Abstract][Full Text] [Related]
16. Sustained release of heparin on enlarged-pore and functionalized MCM-41. Wan MM; Yang JY; Qiu Y; Zhou Y; Guan CX; Hou Q; Lin WG; Zhu JH ACS Appl Mater Interfaces; 2012 Aug; 4(8):4113-22. PubMed ID: 22850329 [TBL] [Abstract][Full Text] [Related]
17. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods. Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084 [TBL] [Abstract][Full Text] [Related]
18. In situ incorporation of nickel nanoparticles into the mesopores of MCM-41 by manipulation of solvent-solute interaction and its activity toward adsorptive desulfurization of gas oil. Samadi-Maybodi A; Teymouri M; Vahid A; Miranbeigi A J Hazard Mater; 2011 Sep; 192(3):1667-74. PubMed ID: 21820806 [TBL] [Abstract][Full Text] [Related]